Prothena Corp Public (PRTA) Accounts Payables (2013 - 2026)
Prothena Corp Public (PRTA) posted quarterly Accounts Payables of $4.3 million for Q1 2026, down 73.18% year-over-year from $16.0 million in Q1 2025, and down 26.83% quarter-over-quarter from $5.9 million in Q4 2025.
Prothena Corp Public (PRTA) Accounts Payables (2013 - 2026) Analysis & Trends
Prothena Corp Public's Accounts Payables history runs 14 years deep, the most recent figure standing at $4.3 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 73.18% year-over-year to $4.3 million; the TTM figure through Mar 2026 stood at $4.3 million (down 73.18% YoY), while the FY2025 annual figure was $5.9 million, down 24.39% from the prior year.
- Accounts Payables for Q1 2026 stood at $4.3 million, down from $5.9 million in the prior quarter.
- The five-year high for Accounts Payables was $25.4 million in Q4 2023, with the low at $4.3 million in Q1 2026.
- The 5-year median for Accounts Payables is $10.3 million (2024), against an average of $11.6 million.
- The sharpest annual moves came in 2022 and 2026: Accounts Payables jumped 181.02% in 2022, then slumped 73.18% in 2026.
- Prothena Corp Public's Accounts Payables stood at $9.3 million in 2022, then soared by 173.91% to $25.4 million in 2023, then plunged by 69.4% to $7.8 million in 2024, then fell by 24.39% to $5.9 million in 2025, then slipped by 26.83% to $4.3 million in 2026.
- Business Quant data shows PRTA's Accounts Payables at $4.3 million in Q1 2026, $5.9 million in Q4 2025, and $10.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | 1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94 Mn |
| Mar 31, 2026 | 4.30 Mn |
| Dec 31, 2025 | 5.88 Mn |
| Sep 30, 2025 | 10.50 Mn |
| Jun 30, 2025 | 12.20 Mn |
| Mar 31, 2025 | 16.03 Mn |
| Dec 31, 2024 | 7.77 Mn |
| Sep 30, 2024 | 10.33 Mn |
| Jun 30, 2024 | 9.29 Mn |
| Mar 31, 2024 | 14.42 Mn |
| Dec 31, 2023 | 25.39 Mn |
| Sep 30, 2023 | 19.46 Mn |
| Jun 30, 2023 | 13.85 Mn |
| Mar 31, 2023 | 12.52 Mn |
| Dec 31, 2022 | 9.27 Mn |
| Sep 30, 2022 | 9.79 Mn |
| Jun 30, 2022 | 7.55 Mn |
| Mar 31, 2022 | 9.32 Mn |
| Dec 31, 2021 | 3.69 Mn |
| Sep 30, 2021 | 3.48 Mn |